TW200716166A - Lawsonia intracellularis immunological proteins - Google Patents

Lawsonia intracellularis immunological proteins

Info

Publication number
TW200716166A
TW200716166A TW095115374A TW95115374A TW200716166A TW 200716166 A TW200716166 A TW 200716166A TW 095115374 A TW095115374 A TW 095115374A TW 95115374 A TW95115374 A TW 95115374A TW 200716166 A TW200716166 A TW 200716166A
Authority
TW
Taiwan
Prior art keywords
seq
sequence homology
polypeptide
sequence
encoded
Prior art date
Application number
TW095115374A
Other languages
English (en)
Chinese (zh)
Inventor
Eric Martin Vaughn
Merrill Schaeffer
Ya-Jie Liang
Jeremy Kroll
Michael B Roof
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of TW200716166A publication Critical patent/TW200716166A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW095115374A 2005-04-28 2006-04-28 Lawsonia intracellularis immunological proteins TW200716166A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67580605P 2005-04-28 2005-04-28
US11/414,764 US20080279893A1 (en) 2005-04-28 2006-04-28 Lawsonia intracellularis immunological proteins

Publications (1)

Publication Number Publication Date
TW200716166A true TW200716166A (en) 2007-05-01

Family

ID=38006679

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095115374A TW200716166A (en) 2005-04-28 2006-04-28 Lawsonia intracellularis immunological proteins

Country Status (6)

Country Link
US (1) US20080279893A1 (fr)
EP (1) EP1877580A4 (fr)
JP (1) JP2009509496A (fr)
AR (1) AR053372A1 (fr)
TW (1) TW200716166A (fr)
WO (1) WO2006116763A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US8470336B2 (en) * 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
US20080241190A1 (en) * 2006-11-13 2008-10-02 Boehringer Ingelheim Vetmedica, Inc. Vaccination of horses against lawsonia intracellularis
EP2859900A1 (fr) 2006-12-11 2015-04-15 Boehringer Ingelheim Vetmedica, Inc. Procédé efficace de traitement du circovirus porcin et des infections par lawsonia intracellularis
EP2200643B1 (fr) 2007-09-17 2013-09-04 Boehringer Ingelheim Vetmedica, Inc. Un vaccin vivant de lawsonia intracellularis administré en association avec un antibiotique pour le traitement des infections de lawsonia intracellularis dans les porcs
WO2010048252A1 (fr) * 2008-10-23 2010-04-29 Intervet International B.V. Vaccins contre lawsonia intracellularis
US20140017268A1 (en) * 2012-06-05 2014-01-16 Regents Of The University Of Minnesota Composition and Methods for Detecting or Preventing Lawsonia intracellularis Infections
CL2017002196A1 (es) 2017-08-30 2017-11-17 Univ De Concepción Vacuna recombinante contra enteropatía proliferativa en animales.
CN112940089B (zh) * 2021-01-27 2022-09-09 湖南康保特生物科技有限公司 胞内劳森菌flgE重组蛋白及胞内劳森菌抗体检测试剂盒

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2236574A1 (fr) * 1995-11-30 1997-06-05 Daratech Pty. Ltd. Compositions therapeutiques et diagnostiques
EP1570045A4 (fr) * 2002-10-04 2007-09-05 Univ Minnesota Sequences d'acides nucleiques et polypeptidiques de lawsonia intracellularis et methodes d'utilisation

Also Published As

Publication number Publication date
WO2006116763A3 (fr) 2007-11-08
US20080279893A1 (en) 2008-11-13
EP1877580A2 (fr) 2008-01-16
JP2009509496A (ja) 2009-03-12
EP1877580A4 (fr) 2008-07-30
WO2006116763A2 (fr) 2006-11-02
AR053372A1 (es) 2007-05-02

Similar Documents

Publication Publication Date Title
TW200716166A (en) Lawsonia intracellularis immunological proteins
US11998597B2 (en) Vaccine against RSV
HRP20231496T1 (hr) Cistein proteaza
JP2014507146A5 (fr)
MX348464B (es) Agente inductor de inmunidad.
EP2319862A1 (fr) Petits antigènes pyogènes streptococcus et leur utilisation
JP2010536333A5 (fr)
JP2009540801A5 (fr)
MY150105A (en) A novel surface exposed haemophilus influenzae protein (protein e; pe)
UA98620C2 (uk) Атенуйований вірус класичної лихоманки свиней, що містить модифікований глікопротеїн е2
RU2012113162A (ru) Белок слияния, содержащий тимусный стромальный лимфопоэтический белок, вакцина, содержащая эскпрессионный вектор для экспресии белка, и вакцина, содержащая указанный вектор для экспрессии
PH12021550030A1 (en) Nucleotide sequences encoding peptide antigens of sars-cov-2 virus and use thereof
HK1129128A1 (en) Recombinant human interferon-like proteins
EP2589658A4 (fr) Polypeptide de région partielle de la protéine reic/dkk-3
JP2012515557A5 (fr)
WO2009024327A3 (fr) Nouvelles protéines pour une utilisation dans des infections par staphylococcus chez des êtres humains et des animaux
WO2010007144A3 (fr) Nouvelles protéines de nétrine 4 mutées, fragments de celles-ci et leurs utilisations en tant que médicaments
JP2012516140A5 (fr)
Egelseer et al. Characterization of an S-layer glycoprotein produced in the course of S-layer variation of Bacillus stearothermophilu s ATCC 12980 and sequencing and cloning of the sbsD gene encoding the protein moiety
WO2006113782A3 (fr) Proteine lawsonia utilisee comme composant dans un vaccin sous-unite et procedes de fabrication et d'utilisation associes
EP1613345A4 (fr) Compositions contenant un virus syncytial respiratoire de la souche 9320 du sous-groupe b, et procedes associes
RU2009115688A (ru) Иммуногенные гибридные полипептиды против ожирения и композиция вакцин против ожирения, содержащая эти полипептиды
DE602005015368D1 (de) Immunogenes polypeptid bestehend aus optimierten kryptischen peptiden aus tumorantigenen und seine verwendungen
ATE466876T1 (de) Immunogene konstrukte
TW200801034A (en) Novel sea lice vaccine